Filter by: Subject

Filter by: Subject

Results Per Page:

Positron emission tomography (PET) (9)
Infection (5)
Prostate cancer (4)
Prostate-specific membrane antigen (PSMA) (4)
Radiopharmaceuticals (4)
Antimicrobial peptide (AMP) (3)
Molecular imaging (3)
PET/CT (3)
Positron emission tomography/computed tomography (PET/CT) (3)
Theranostics (3)
Ubiquicidin (3)
68Ga (2)
68Ga-PSMA (2)
Bacteria (2)
Biodistribution (2)
DOTA (2)
Infection imaging (2)
Microemulsion (2)
NODAGA (2)
Nuclear medicine (2)
Prostate carcinoma (2)
Radiochemistry (2)
Radiolabeling (2)
Radiotracers (2)
Tuberculosis (TB) (2)
18F-FDG PET/CT (1)
68Ga labeling (1)
68Ga NOTA-UBI (1)
68Ga-citrate PET/CT (1)
68Ga-DKFZ-PSMA-11 (1)
68Ga-HBED-CC-(Ahx)Lys-NH-CO-NH-Glu (1)
68Ga-NOTA-UBI (1)
68Ga-PSMA PET/CT (1)
68Ga-PSMAHBED (1)
68Ga/68Ge generator (1)
68Gallium (1)
68Ga‐PSMA‐617 (1)
68Ge/68Ga generator (1)
[213Bi]Bi-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[68Ga]Ga-NODAGAZOL (1)
[68Ga]Ga-PSMA-11 (1)
[68Ga]Ga-PSMA-617-ME (1)
[68Ga]Ga1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-[Thi8 , Met(O2 ) 11]-Substance-P (1)
[89Zr]IIIB6 (1)
[99mTc]Tc-MDP (1)
Active ingredients (1)
Alpha(nu)beta(3)-integrin (1)
Angiogenesis (1)
Antibiotic-derived PET (1)
Antimicrobial peptides (1)
Automated synthesis (1)
Biologival evaluation (1)
Black South-African (BSAs) (1)
BODIPY-based dyes (1)
Bone scan (1)
Boron dipyrromethene (BODIPY) (1)
Breast cancer (1)
Carboxylic acid group (1)
Cardiac implantable electronic device (CIED) (1)
Cathelicidin (1)
Cathelicidin-derived peptide (CDP1) (1)
CDP1 (1)
Clinic (1)
Clinical application (1)
Colloid-labeled-leukocytes (1)
Computerized tomography (CT) (1)
Controlled drug delivery (1)
Depsidomycin-derived compounds (1)
Depsipeptides (1)
Diagnosis (1)
DOTA-Substance P (1)
DOTA-TBIA101 (1)
Drug carrier system (1)
Drug carrier systems (1)
Drug delivery system (1)
Escherichia coli (1)
Fluorescence imaging (1)
Fluorine-18 ubiquicidin (1)
Gallium-68 (1)
Gallium-68 (Ga-68) (1)